MEVO SEC filings, in plain English
Everything M Evo Global Acq II has filed with the SEC that we hold — 26 filings, newest first, 24 with a plain-English summary of what changed and why it matters. Every row links to the primary document on EDGAR, so you can check the source rather than trust us.
The feed
live EDGAR captureNew filings appear here within minutes of hitting EDGAR; summaries follow once the pipeline has read them.
What changed: A Schedule 13G/A Amendment to a Beneficial Ownership Report, comprising two renewed Powers of Attorney executed by The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC to authorize designated personnel to file required Securities Exchange Act disclosures. According to the attached exhibits, the filing supersedes previously granted Powers of Attorney dated July 16, 2025. The documents establish new expiration dates of July 8, 2027 for The Goldman Sachs Group, Inc. and July 2, 2027 for Goldman Sachs & Co. LLC, and appoint a specific roster of attorneys-in-fact including Sadhiya Raffique, Santosh Vinayagamoorthy, D Guru Prasad, Tobi Amusan, Akash Keshari, Papa Lette, Andrzej Szyszka, Rahail Patel, Taiki Misu, Regina Chan, Abhilasha Bareja, Veronica Mupazviriwo, Sam Prashanth, Ameen Soetan, Abhishek Vishwanathan, Elizabeth Novak, and Matthew Pomfret. The filing states the authority covers Rule 13f-1 and Regulation 13D-G obligations under the Securities Exchange Act of 1934, permits unilateral revocation at any time, and automatically terminates for any attorney who ceases employment or function before the expiration dates. Why it matters: Per the filing text, this submission bears absolutely no bearing on the January 30, 2028 redemption deadline, the reported $10.14 trust value per share, any potential extension mechanisms, business combination progress, or sponsor conduct. Because the document functions exclusively as an administrative renewal for regulatory signature authority, it does not trigger redemption options, modify the trust account timeline, alter MEVO’s SEARCHING designation, or signal any operational or strategic shifts. No material changes to shareholder economics, exit mechanics, or deal pipeline are presented.
What changed: Quarterly Report (Form 10-Q) for M Evo Global Acquisition Corp II, filed 2026-08-12 for the quarter ended June 30, 2026. This is the first periodic report since the SPAC closed its IPO on February 2, 2026. The trust, funded with $300,000,000 on February 2, 2026, has grown to $304,335,691 (including $4,335,691 of interest income). The redemption value per share is $10.14. The Company recorded an $8,469,916 compensation expense for founder shares granted to directors on January 29, 2026, a non-cash item. Cash and cash equivalents outside trust are $947,796; working capital is $978,656. Accretion of the Class A shares to redemption value continued, with $2,670,170 charged to accumulated deficit in Q2 2026. There is no announced deal or letter of intent; the Company states it is still 'identifying a target company for a Business Combination.' The deadline to complete a deal is 24 months from the IPO closing (February 2, 2026), or approximately January 30, 2028. Why it matters: This filing confirms the SPAC is fully funded, searching for a target, and on a standard timeline. The trust value per share is $10.14, providing a baseline for any future redemption. The high non-cash compensation charge is a one-time IPO-related event and does not represent cash burn from operations. There are no new disclosures of a signed business combination agreement, extension requests, or sponsor conduct changes. For redemption calendar tracking, the trust value of $10.14 and the January 30, 2028 deadline are the key mechanics.
What changed vs 2026-05-08trust $301.7M → $304.3M +1%trust account, sponsor loans outstanding, redeemable shares1 moved · 2 with no prior record of ours
- Trust account
- $301.7M$304.3M
- Sponsor loans outstanding
- $300K · unchanged
- Redeemable shares
- 30.0M · unchanged
SpacBrain reads this as $2,670,170 was added to the trust between the two filings.
The clause “Deferred offering costs 213,407 Prepaid insurance long-term 40,710 Investments held in Trust Account 304,335,691 TOTAL ASSETS $ 305,458,981 $ 243,667 LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS”…
The clause “Sponsor of up to $ 300,000 . On February 2, 2026, the Company repaid the total outstanding balance of the Promissory Note amounting to $ 300,000 (see Note 6). As of June 30, 2026 and December 31, 2025, the Company had cash and cash”…
The clause …“value; 500,000,000 shares authorized; none issued or outstanding (excluding 30,000,000 shares subject to possible redemption) as of June 30, 2026 and December 31, 2025 Class B ordinary shares, $ 0.0001 par value; 50,000,000 shares”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: This document is a Schedule 13G, stated in its own terms as a “beneficial ownership report,” filed by Aristeia Capital, L.L.C. Regarding SPAC mechanics, the filing contains no data on redemption windows, trust value maintenance, extension timelines, target search progress, or sponsor conduct. As disclosed by Aristeia Capital, L.L.C., the submission solely registers their equity position without detailing share quantities, acquisition pricing, or any transactional events that would alter liquidation preferences or shareholder approval thresholds. Why it matters: Registration of a 5%+ beneficial owner triggers ongoing Section 13(d) disclosure obligations that can signal an investor’s capacity to influence director nominations, approve indenture amendments, or affect the sponsor’s business combination timeline, although this specific filing attributes no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel to the holder and includes no financial or operational metrics.
What changed: A Joint Acquisition Statement exhibited as Exhibit 99.1 to a Schedule 13G beneficial ownership report, filed pursuant to Rule 13d-1(k) by Adage Capital Management, L.P., Robert Atchinson, and Phillip Gross. The filing establishes that the three named parties will submit all future Schedule 13G amendments jointly. As acknowledged by the undersigned signatories, each party assumes independent responsibility for the completeness and accuracy of their own disclosed information while expressly disavowing responsibility for the others’ filings except where they know or have reason to believe such information is inaccurate. No change in share count, ownership percentage, or transaction economics is disclosed in this excerpt. Why it matters: For investors monitoring MEVO’s redemption timeline, trust value, extension options, merger progress, or sponsor behavior, this document provides no operative updates. The exhibit contains no commentary on business combination targets, shareholder voting intentions, redemption preferences, or any alteration to the trust account structure or corporate deadlines referenced in the SPAC’s prospectus. The joint filing arrangement reflects routine SEC compliance coordination rather than strategic positioning, and because it is purely administrative, it does not materially affect the SPAC’s capital structure, timeline, or investor protection mechanisms.
What changed: A Schedule 13G filing that attaches two Power of Attorney exhibits executed by The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC to designate internal authorized signatories for SEC reporting obligations. The filing contains no updates to MEVO’s redemption deadline of January 30, 2028, trust value of $10.14 per share, extension voting procedures, target acquisition progress, or sponsor governance. The only operational change is an administrative delegation: both Goldman Sachs entities appointed eighteen named individuals—including Sadhiya Raffique, Santosh Vinayagamoorthy, D Guru Prasad, Tobi Amusan, Akash Keshari, Papa Lette, Andrzej Szyszka, Rahail Patel, Taiki Misu, Regina Chan, Mariana Audeves Martinez, Asheesh Bajaj, Abhilasha Bareja, Veronica Mupazviriwo, Sam Prashanth, Ameen Soetan, Abhishek Vishwanathan, Elizabeth Novak, and Matthew Pomfret—as attorneys-in-fact to execute and deliver filings under Rule 13f-1 and Regulation 13D-G on their behalf through July 16, 2026. As expressly stated in the exhibits, this delegation supersedes prior powers of attorney dated July 29, 2024, and October 1, 2024, and either entity retains the unrestricted right to unilaterally revoke it or terminate individual attorneys-in-fact upon cessation of employment or function. Why it matters: For investors monitoring the redemption calendar, trust account integrity, and sponsor behavior, this filing confirms that beneficial ownership reporting continues under routine institutional housekeeping without shifting voting intent, changing the $10.14 trust baseline, or altering the January 30, 2028, liquidation clock. Because the exhibits are purely procedural, they contain no statements from MEVO’s sponsor, management team, or potential business combination targets. There are no reported claims regarding customer contracts, revenue runs, addressable market sizing, technology milestones, strategic partnerships, litigation posture, or key executive hires or departures. The document reflects standard portfolio administration for 13D-G compliance and carries no direct mechanistic impact on redemptions, merger extensions, or capital deployment.
What changed: Quarterly Report (Form 10-Q) for the period ended March 31, 2026. First 10-Q filing post-IPO. Reports $7.0 million net loss driven by $8.5 million non-cash compensation expense from founder share grants, partially offset by $1.7 million trust interest. Trust holds $301.7 million ($10.06/share). Sponsor purchased 5M private warrants; underwriters bought 3M. Founder shares fully vested after over-allotment exercise. 24-month deadline to complete a business combination. Why it matters: Provides baseline financial position after IPO, establishes trust value ($10.06/share, above $10.00 per unit), confirms founder share compensation expense, and sets 24-month deadline (February 2028) for deal completion.
What changed: Form 8-K current report (accompanied by Exhibit 99.1 press release) functioning as a routine compliance announcement detailing the structural separation and subsequent dual-trading of the Company’s public shares and warrants. Per the press release dated February 18, 2026, and signed by Chief Executive Officer Stephen Silver, the Company announced that beginning February 19, 2026, holders may elect to separate the Units from the initial public offering completed on February 2, 2026. Each original Unit contains one Class A ordinary share (par value $0.0001 per share) and one-half of one redeemable warrant, with each whole warrant granting the right to purchase a share at $11.50 per share, subject to adjustment. Separated shares will trade under “MEVO,” warrants under “MEVOW,” and undivided units continue as “MEVOU” on the Nasdaq Global Market. The Company specified that no fractional warrants will be issued upon division; only whole warrants will trade. Investors must direct their brokers to coordinate with transfer agent Continental Stock Transfer & Trust Company to effect the split. This announcement does not trigger a redemption window change, extend the business combination timeline, adjust the trust account balance per share, reveal deal progress, or indicate modifications to sponsor conduct. Why it matters: For investors monitoring mechanical and strategic developments, the filing primarily alters secondary market liquidity options rather than fundamental valuation or timeline parameters. Procedurally, it discloses the underwriting team: Cohen & Company Capital Markets acted as lead book-running manager and Clear Street LLC served as co-manager. Substantively, the press release reiterates the Company’s investment mandate, stating it was formed to pursue a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with a explicit focus on entities owning, operating, or developing assets in the critical minerals sector that are fundamental to the economic and national security interests of the United States. Standard forward-looking disclaimers warn that completion of a business combination is subject to numerous uncertainties detailed in the prospectus effective January 31, 2026. The document contains no disclosures regarding customer contracts, historical revenue, market size projections, technology roadmaps, commercial partnerships, active litigation, or executive personnel changes beyond the signing officer.
What changed: A Form 8-K Current Report filed by M Evo Global Acquisition Corp II announcing the consummation of its Initial Public Offering and simultaneous private placement of warrants on February 2, 2026, accompanied by an audited balance sheet dated that same day and comprehensive financial statement notes prepared under U.S. GAAP. According to the filing, mechanics shifted when the Company completed its IPO of 30,000,000 Units at $10.00 per Unit, generating $300,000,000 in gross proceeds, which included the full exercise of the underwriters’ 3,000,000 Unit over-allotment option. Simultaneously, 8,000,000 Private Placement Warrants were sold for $1.00 each, raising $8,000,000; the Sponsor, Evolution Sponsor Holdings LLC II, purchased 5,000,000, while Cohen & Company Capital Markets and Clear Street, LLC acquired 2,285,000 and 150,000 respectively. Management states that as of February 2, 2026, $300,000,000 was deposited into a Trust Account for public shareholders, establishing the baseline for future redemption valuations. The registrant established a 24-month Completion Window to finalize a Business Combination, defining the operational timeframe relative to the February 2, 2026 closing. The underwriters hold a $12,000,000 deferred underwriting commission ($0.40 per Unit) that is contractually waived if no Business Combination occurs within the Completion Window. Public shareholders retain redemption rights to receive a pro rata portion of the Trust, initially structured at $10.00 per share plus qualifying interest. The Sponsor finalized ownership of 10,000,000 Founder Shares after forfeiting up to 1,000,000 shares due to the over-allotment exercise. Administrative service agreements require payments of $15,000 per month for 15 months, followed by $7,500 per month, while Stephen Silver, identified as Chief Executive Officer and Chairman, oversees Evolution Capital Pty Ltd, which received a $900,000 advisory fee upon closing. Why it matters: Beyond the mechanics, the document contains substantive disclosures regarding trust protection, warrant dilution, and corporate governance. Because the Trust holds exactly $300,000,000, any future redemption calculations or extension voting scenarios will reference that precise principal plus qualifying interest, rather than importing a standardized assumption. The waiver of the $12,000,000 deferred underwriting fee in a termination scenario increases the pool available for shareholder returns if no deal closes. The filing details warrant economics that affect capital structure: 15,000,000 Public Warrants and 8,000,000 Private Placement Warrants carry an $11.50 exercise price, expire five years post-combination, and include a cash-call provision triggered if Class A ordinary shares close at or above $18.00 per share for 20 of 30 trading days. Adjustments to warrant pricing apply if capital raised during the Business Combination falls below a Newly Issued Price of $9.20 and represents more than 60% of equity funding, with a Market Value below $9.20. Working capital lenders retain the option to convert up to $1,500,000 of loans into warrants at $1.00 per warrant. The filing lists transaction costs totaling $18,662,204, allocated as $5,100,000 in cash underwriting fees net of a $900,000 reimbursement and $1,562,204 in other offering costs. Management indicates the Company will generate no operating revenues until a Business Combination completes, relying instead on interest income from the Trust invested in U.S. government treasury obligations maturing within 185 days or Rule 2a-7 money market funds. The sponsor has contractually agreed to be liable to the Company if third-party claims drain the Trust below the lesser of $10.00 per Public Share or the actual per-share amount, minus applicable taxes and up to $100,000 for liquidation expenses, excluding claims from parties who executed waivers or underwriter indemnities. The audited balance sheet shows $1,217,506 in working cash, $159,330 in current liabilities, and a $10,767,164 shareholders’ deficit driven by accumulated costs. Additional disclosures note that $14,805 was paid for membership interests equivalent to 3,443,055 Founder Shares with a recorded fair value of $8,469,916, and independent auditors WithumSmith+Brown, PC priced Public Warrants at $4,350,000 ($0.29 per warrant) using assumptions including a $9.85 implied share price, 25.0% probability of de-SPAC, 4.01% risk-free rate, and 2.5% selected volatility.
What changed: A routine compliance exhibit — specifically a Joint Filing Agreement (Exhibit 99.1) executed on February 3, 2026, by Evolution Sponsor Holdings LLC II (via Managing Member Stephen Silver) and Ashley Zumwalt, formally consolidating their obligations to submit a single Schedule 13D under Securities Exchange Act Rule 13d-1(f). The document contains no beneficial ownership tables, transaction pricing, share quantities, or stated purposes for acquiring securities. It does not alter redemption calendar parameters, trigger trust distribution calculations, propose a business combination timeline shift, authorize a time extension, or detail sponsor conduct. As a procedural appendix to the primary regulatory filing, it merely establishes that multiple entities are bundling their disclosure submissions. Why it matters: This attachment confirms the administrative alignment between the SPAC’s sponsor vehicle and an affiliated investor, indicating coordinated reporting of a recent equity position. Because the substantive 13D data (which would disclose exact ownership percentages, sources of funds, and investment intent relevant to the SEARCHING phase) is not present in this excerpt, the document carries no direct impact on shareholder exit valuations, merger negotiation pacing, or governance oversight. It functions solely as a regulatory housekeeping measure rather than a strategic or operational disclosure.
What changed: An 8-K Current Report filed by M Evo Global Acquisition Corp II (MEVO) reporting the closing of its initial public offering (IPO) and the entry into related material definitive agreements, filed on February 3, 2026. The Company consummated its IPO on February 2, 2026, selling 30,000,000 units (including full exercise of the underwriter's over-allotment option) at $10.00 per unit, generating $300,000,000 in gross proceeds. A total of $300,000,000 was placed in a trust account. Simultaneously, the Company completed the private sale of 8,000,000 private placement warrants at $1.00 each, generating $8,000,000 in gross proceeds. The Company also adopted its Amended and Restated Memorandum and Articles of Association and entered into all standard IPO-related agreements (underwriting, warrant, registration rights, letter, trust, private placement warrant purchase, advisory, administrative services, and indemnity agreements). Separate trading of the shares and warrants has not yet begun; it will commence on the 52nd day after the prospectus date or earlier with underwriter consent, subject to the filing of an audited balance sheet and a press release. The deadline to complete an initial business combination is 24 months from the closing of the IPO (February 2, 2028), extendable with shareholder approval. Why it matters: This filing marks MEVO's transition from a blank-check company in formation to a public, cash-rich SPAC with a $300 million trust (approximately $10.14 per share) actively searching for a target. The stated focus is the critical minerals sector. The full exercise of the over-allotment option increases the trust size by $30 million. Key lock-up periods for the sponsor and insiders are established: 180-day IPO lock-up, 1-year founder share lock-up, and 30-day private placement warrant lock-up post-business combination. These terms are standard for a newly formed SPAC.
What changed: An IPO prospectus (Rule 424(b)(4) filing) establishing the initial public offering of M Evo Global Acquisition Corp II units. This prospectus codifies the foundational mechanics for redemptions, trust maintenance, extensions, and sponsor compensation ahead of any target search. Per the filing, proceeds of $270,000,000 (or $300,000,000 if the underwriters exercise their 3,000,000-unit over-allotment option) will be deposited into a U.S.-based trust account maintained by Continental Stock Transfer and Trust Company, reflecting a stated $10.00 per unit placement. Why it matters: Investors receive a complete, pre-negotiated capital structure before target identification, enabling accurate modeling of dilution floors and liquidity exits. The 15% single-entity redemption cap materially alters standard SPAC dynamics by protecting the trust account from being stripped by coordinated activist campaigns or algorithmic trading, thereby preserving capital for larger transactions. The mandatory deduction of up to $100,000 for liquidation expenses ensures the final per-share distribution will mathematically trail the gross trust balance.
What changed: SEC Form 3 – Initial Statement of Beneficial Ownership by Insiders. The filing records that Chief Financial Officer Chen Arthur Kuan-Lin submitted an initial ownership report containing no non-derivative transactions or holdings. Why it matters: This document is a routine regulatory trigger filed when an individual assumes an executive or directorship role to establish a baseline of reported equity. Because the reporting person explicitly states there are no non-derivative transactions or holdings to report, it introduces no new insider purchases, sales, or option exercises that would signal capital commitment or risk tolerance ahead of a target acquisition. As such, the submission provides no observable update on the sponsor’s operational conduct, acquisition search velocity, or governance posture, and carries no mechanical impact on shareholder redemption calculations, trust account maintenance protocols, or extension voting timelines. The filing simply fulfills statutory reporting obligations without generating new intelligence for tracking the SPAC’s liquidity runway or management alignment.
What changed: SEC Form 3, an initial statement of beneficial ownership of securities filed as a routine compliance exhibit for insider reporting. According to the report filed on 2026-01-29, reporting person Stephen Marc Silver (director, CEO and Chairman) disclosed no non-derivative transactions or holdings. There were no insider purchases, sales, or position changes relative to MEVO shares. Why it matters: For investors tracking redemption deadlines, trust value, extensions, deal progress, and sponsor conduct, this zero-activity disclosure means there is no new insider capital commitment, stock purchase signal, or governance shift ahead of the January 30, 2028 deadline or against the $10.14 trust/share. The filing leaves redemption mechanics and sponsor positioning unchanged. Beyond confirming the reporting period and identity of the director/CEO/Chairman, the document contains no substantive claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel.
What changed: A Form 3 initial statement of beneficial ownership of securities, filed with the SEC by reporting person Ichilov Erez (director) for M Evo Global Acquisition Corp II. The filing text explicitly states: 'No non-derivative transactions or holdings reported.' Consequently, there are no updates to insider equity positions, which translates to no direct impact on redemption pressure mechanics, trust account valuation adjustments, extension timeline triggers, merger deal progression, or sponsor conduct indicators. Why it matters: Investors tracking the SEARCHING SPAC against its 2028-01-30 business combination deadline should note that this routine compliance exhibit introduces no operational data, strategic updates, or capital deployment signals. As reported by the filer, zero equity movements occurred. Therefore, nothing alters redemption calendar modeling, trust-per-share tracking, or evaluation of director alignment, and no new claims regarding customers, revenue, market size, technology, partnerships, litigation, or personnel are present to weigh against the firm’s search-stage execution.
What changed: Form 8-A filing registering specific classes of securities for quotation on The Nasdaq Stock Market LLC pursuant to Section 12(b) of the Securities Exchange Act of 1934. The registrant formally listed Class A ordinary shares (par value $0.0001), Redeemable Warrants exercisable for one Class A ordinary share at $11.50 per share, and Units comprising one Class A ordinary share and one-half of one Redeemable Warrant. The filing states that no securities are being registered under Section 12(g) and that no exhibits are required. Why it matters: This routine listing confirmation locks in the public warrant strike price at $11.50 and defines the unit composition trading on Nasdaq. Because the document contains no operational disclosures, target announcements, or timeline adjustments, it serves only as an administrative registry update. As noted in the filing and signed by Chief Executive Officer Stephen Silver, governance continues through the extended SEARCHING phase, but zero deal progress, revenue claims, market-size projections, or partnership mentions are disclosed.
What changed: This is an S-1MEF registration statement filed pursuant to Rule 462(b) of the Securities Act of 1933, registering an additional 4,500,000 units of M Evo Global Acquisition Corp II, with each unit composed of one Class A ordinary share and one-half of one redeemable warrant. M Evo Global Acquisition Corp II states it is adding these 4,500,000 units to its existing shelf under File No. 333-292138, which the registrant notes became effective at 4:00 p.m. Eastern Time on January 29, 2026. Why it matters: For investors tracking the stated $10.14 per-share trust value and the 2028-01-30 deadline, this filing leaves the liquidity window, redemption threshold, and target-acquisition timeline untouched. Filing additional units under Rule 462(b) typically increases public float or reserves for transaction expenses without altering sponsor control or converting the search-phase status into a merger timetable.
What changed: A Form 3 initial statement of beneficial ownership of securities filed with the Securities and Exchange Commission. The filing discloses that Evolution Sponsor Holdings LLC II, described by the filer as a 10% owner of M Evo Global Acquisition Corp II, had 'No non-derivative transactions or holdings reported' on 2026-01-29. The document contains no updates regarding shareholder redemption thresholds, trust account movements, extension amendments, or target acquisition negotiations. Why it matters: For investors monitoring the SPAC’s stated trust value of $10.14 per share and its contractual search deadline of 2028-01-30, this zero-activity report confirms the sponsor’s equity position remained static through the filing date. By formally reporting no purchases, sales, or derivative adjustments, Evolution Sponsor Holdings LLC II signals no shift in sponsor alignment or financial commitment ahead of the deadline. The submission functions as a statutory compliance checkpoint rather than a mechanism that alters redemption economics or extension voting dynamics, meaning capital allocation decisions must continue to rely on existing trust metrics and prior public disclosures.
What changed: Form 3 — insider ownership report. This document IS a Form 3 insider ownership report. Reporting person Ashley Elizabeth Zumwalt-Forbes (director, Chief Operating Officer) discloses no non-derivative transactions or holdings. Regarding mechanics: the filing contains no statements, amendments, or figures altering the existing redemption deadline, trust ledger, extension status, or business combination progress. Sponsor conduct is unaddressed. Substance: No claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or executive changes appear beyond standard corporate titles. Why it matters: Confirms routine SEC insider disclosure compliance without advancing the search timeline or shifting shareholder redemption calculus. The absence of reported equity positions by operating leadership leaves the capital structure and combination clock unchanged pending future merger activity.
What changed: A Form 3 initial statement of beneficial ownership, classified as an insider ownership report. First, this document is a Form 3 insider ownership report. Then, regarding mechanics: the filing attributes no non-derivative transactions or holdings to director Craig McLane, yielding zero change to the 2028-01-30 search deadline, the $10.14 trust-per-share value, extension status, business combination progress, or sponsor conduct. Then, regarding other substance: the document contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel; it solely records the reporting person’s stated lack of non-derivative activity, as disclosed by the SEC electronic system for issuer M Evo Global Acquisition Corp II. Why it matters: Investors monitoring the redemption calendar, trust valuation, or extension triggers see no shift to the 2028-01-30 target date or the $10.14 per-share trust floor. The absence of reported insider equity movement establishes a neutral compliance baseline, confirming neither capital inflows/outflows nor shifts in sponsor alignment that would materially alter redemption dynamics or merger timelines.
What changed: An SEC Form 3 insider ownership report identifying Meka Aidan as a director of M Evo Global Acquisition Corp II. The filing explicitly states there are no non-derivative transactions or holdings reported, confirming zero change in beneficial ownership or transactional activity for the named director on this date. Why it matters: This submission bears no mechanical impact on redemption deadlines, trust valuation, extension procedures, target identification progress, or sponsor conduct. Beyond the ownership reporting framework, the document contains no substantive disclosures regarding customers, revenue streams, market size estimates, corporate strategy, technology development, partnership arrangements, litigation status, or personnel movements. No claims are attributed to the issuer, management, or legal counsel, and no numerical or operational data is presented. As a routine Section 16 compliance filing declaring zero reported activity, it delivers no actionable signals for calendar tracking or fundamental evaluation.
What changed: Form S-1/A Amendment No. 2 filed as an exhibits-only registration statement update under the Securities Act of 1933 for M Evo Global Acquisition Corp II. Per Item 13, the registrant reports estimated non-underwriting issuance expenses totaling $550,000, itemized as $250,000 for legal fees, $80,000 for Nasdaq listing, $30,000 for printing, $40,000 for accounting, $100,000 for FINRA and SEC filings, $15,000 for custody, $10,000 for travel and roadshows, and $25,000 for miscellaneous costs. Per Item 14, the registrant discloses that officers and directors have contractually waived any right or claim against trust account monies (preserving rights only from public share ownership) and states the company expects to purchase directors’ and officers’ liability insurance. Per Item 15, Evolution Sponsor Holdings LLC II paid $25,000 (approximately $0.003 per share) on August 22, 2025, for 8,333,333 Class B ordinary shares, with up to 833,333 shares subject to surrender for no consideration based on the underwriters’ over-allotment exercise. The same section states the sponsor and underwriters committed to purchase an aggregate of 6,500,000 private placement warrants (escalating to 7,000,000 with full over-allotment) at $1.00 per warrant for $6,500,000 in total, allocating 4,250,000 warrants (or 4,500,000) to the sponsor and 2,250,000 (or 2,500,000) to the underwriters. Exhibit 107 recalculates the registration fee table to show a net fee due of $6,617.29 against $47,759.58 previously paid, driven by a maximum aggregate offering price of $250,000,000.00 for 25,000,000 units at a proposed maximum price of $10.00 per unit. Under the exhibit index, the registrant lists a Management Consulting & Corporate Advisory Services Agreement with Evolution Capital Pty Ltd, an Administrative Services Agreement with Evolution Sponsor Holdings LLC II, and a Promissory Note issued to the sponsor. Why it matters: The amendment defines the exact transaction expense drain ($550,000 payable from non-trust sources) and locks in the insider equity and warrant allocation mechanics that will determine post-offering voting power and dilution. Because Item 14 confirms the absolute contractual waiver of insider claims against the trust account, public shareholder redemption values are insulated from director or officer indemnity demands, though the registrant simultaneously acknowledges that fulfilling any future indemnification obligations will require sufficient operating liquidity outside the trust or a consummated initial business combination. The disclosed advisory relationship with Evolution Capital Pty Ltd introduces a third-party service provider whose scope of work could influence target identification or execution workflows. The filing does not amend the search period, adjust the trust accounting framework, modify the redemption deadline, or advance a specific business combination target.
What changed: Amendment No. 1 to Form S-1 Registration Statement for the initial public offering of M Evo Global Acquisition Corp II. Updated financial statements as of December 31, 2025, and revised preliminary prospectus dated January 23, 2026, reflecting ongoing SEC review process; no target business identified yet. Why it matters: Provides updated trust account balance ($10.14 per share implied), confirms 24-month deadline to complete business combination, and reiterates redemption mechanics; no substantive discussions with any target commenced.
What changed: S-1 registration statement for the initial public offering of a SPAC, M Evo Global Acquisition Corp II. N/A — this is a first-time, new IPO filing. It establishes the SPAC's terms: 22,500,000 units at $10.00, each unit = 1 Class A share + 1/3 warrant, with 24 months to find a target in the critical minerals sector. Trust is $10.00/share. Sponsor has 8,333,333 founder shares at $0.003 per share. Why it matters: The filing establishes the base terms for the SPAC's redemption, trust, extension, and sponsor economics. Key items: (1) 24-month deadline from closing, can be extended with shareholder vote & redemption rights. (2) Anti-dilution for founder shares: if additional shares/equity-linked securities are issued for the business combination, founder shares convert to maintain 25% ownership. (3) 15% cap on redemptions without sponsor consent if a shareholder vote is held. (4) The deferred underwriting commission ($0.40/unit) is only paid from the trust account *after* all redemptions, so the sponsor has incentive to minimize redemptions. (5) a non-managing sponsor investor (two accredited investors) is buying 1.889M private placement warrants. The SPAC is searching, with no target identified.
What changed: Draft Registration Statement on Form S-1 (Preliminary Prospectus) filed by M Evo Global Acquisition Corp II to register 22,500,000 units for an initial public offering. The filing initiates the IPO registration, establishing the public offering price at $10.00 per unit, a trust deposit target of $225,000,000 ($10.00 per public share), and a 24-month window to consummate a business combination extendable up to 36 months upon shareholder approval. Why it matters: The prospectus states that the sponsor’s $0.003 per share founder share purchase price, combined with anti-dilution conversion rights preserving a 25% ownership stake, will cause immediate and substantial dilution to public shareholders regardless of redemption levels. The registrant discloses that the 36-month maximum extension window alters traditional liquidation timelines, though public shareholders retain redemption rights if an extension is approved.
In plain English
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.